1. Home
  2. BEEP vs CRDL Comparison

BEEP vs CRDL Comparison

Compare BEEP & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mobile Infrastructure Corporation

BEEP

Mobile Infrastructure Corporation

HOLD

Current Price

$3.06

Market Cap

111.2M

Sector

Finance

ML Signal

HOLD

Logo Cardiol Therapeutics Inc.

CRDL

Cardiol Therapeutics Inc.

HOLD

Current Price

$1.02

Market Cap

97.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BEEP
CRDL
Founded
2015
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
111.2M
97.3M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
BEEP
CRDL
Price
$3.06
$1.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$6.75
$9.00
AVG Volume (30 Days)
42.9K
348.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
90.20
N/A
EPS
N/A
N/A
Revenue
$37,008,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.97
N/A
P/E Ratio
N/A
N/A
Revenue Growth
22.25
N/A
52 Week Low
$2.50
$0.77
52 Week High
$4.67
$1.59

Technical Indicators

Market Signals
Indicator
BEEP
CRDL
Relative Strength Index (RSI) 51.20 51.63
Support Level $3.04 $1.03
Resistance Level $3.25 $1.09
Average True Range (ATR) 0.20 0.06
MACD -0.02 0.00
Stochastic Oscillator 52.29 41.62

Price Performance

Historical Comparison
BEEP
CRDL

About BEEP Mobile Infrastructure Corporation

Mobile Infrastructure Corp focuses on acquiring, owning, and leasing parking facilities and related infrastructure, including parking lots, parking garages and other parking structures throughout the United States. It operates in a single reportable segment: parking. The parking segment derives revenue from managed property revenue and rental income at parking facilities. The company provide access to property and space for the parker's vehicle and charges fees that vary based on the level of usage. The company derives all of its revenue domestically.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Share on Social Networks: